MTMichael R. Tadross

Michael R. Tadross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael R. Tadross has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Connectomic dopamine-neuron disinhibition accelerates behavioral extinction

    by Sasha C.V. Burwell, Rene K. Carter, Haidun Yan, Shaun S.X. Lim, Brenda C. Shields, Michael R Tadross

    Animals must balance persistence with flexibility when outcomes change. Behavioral extinction—the reduction in responding to cues that no longer predict reward—is widely thought to be driven by pauses in dopamine-neuron firing upon omission of expected rewards. However, whether these pauses are necessary remains unknown. We used a connectomic intervention to weaken inhibitory synapses onto dopamine neurons in the ventral tegmental area, attenuating electrophysiologically defined pauses while sparing tonic and burst firing. Contrary to canonical accounts, this intervention accelerated rather than delayed behavioral extinction, demonstrating that these synapses normally postpone behavioral extinction. Learning about a newly rewarded cue was spared, arguing against a general disruption of learning. Dopamine photometry showed that the intervention attenuated reward-omission dopamine dips, whose dissipation preceded and predicted behavioral extinction across mice. These findings show that pause-generating inhibitory inputs to dopamine neurons sustain behavioral persistence. This mechanism may protect established associations from premature abandonment as outcomes fluctuate.

  • A cholinergic hub in the nucleus accumbens gates opioid-reward learning

    by S. Aryana Yousefzadeh, Haidun Yan, Seung-Hwa Kwak, Yunju Oh, Pyeonghwa Jeong, Vladimir Pogorelov, J. Russell Ravenel, Shaun S. X. Lim, James M. Roach, Brenda C. Shields, et al.


  • Open Access

    A general one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging

    by Kilian Roßmann, Ulrich Pabst, Bianca C. Baciu, Siqi Sun, Christiane Huhn, Christina Holmboe Olesen, Maria Kowald, Eleni Tapp, Marie Bieck, Ramona Birke, et al.

    Visualization of proteins can be achieved by genetically grafting HaloTag Protein (HTP) into the protein of interest followed by incubation with a dye-linked HaloTag Ligand (HTL). This approach allows for use of fluorophores optimized for specific optical techniques or of cell-impermeable dyes to selectively label cell surface proteins. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Here we show that several dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed, using a one-step protocol. We validate such compounds, termed dye-SHTL (dye shuttle), in living cells, and demonstrate exclusive membrane staining. In transduced primary hippocampal neurons, we label a neuromodulatory receptor with dyes optimized for stimulated emission by depletion super-resolution microscopy, allowing accuracy in distinguishing surface versus internal receptors of the presynaptic terminal. This approach offers broad utility for surface-specific protein labelling.


  • Open Access

    A one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging

    by Kilian Roßmann, Siqi Sun, Christina Holmboe Olesen, Maria Kowald, Eleni Tapp, Ulrich Pabst, Marie Bieck, Ramona Birke, Brenda C. Shields, PyeongHwa Jeong, et al.

    Communication between cells is largely orchestrated by proteins on the cell surface, which allow information transfer across the cell membrane. Super-resolution and single-molecule visualization of these proteins can be achieved by genetically grafting HTP (HaloTag Protein) into the protein of interest followed by brief incubation of cells with a dye-HTL (dye-linked HaloTag Ligand). This approach allows for use of cutting-edge fluorophores optimized for specific optical techniques or a cell-impermeable dye-HTL to selectively label surface proteins without labeling intracellular copies. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Traditional methods to eliminate cell permeability face synthetic bottlenecks and risk altering photophysical properties. Here we report that dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed. This simple, one-step method requires no purification and is compatible with both the original HTL and second-generation HTL.2, the latter offering accelerated labeling. We validate such compounds, termed dye-SHTL (‘dye shuttle’) conjugates, in live cells via widefield microscopy, demonstrating exclusive membrane staining of extracellular HTP fusion proteins. In transduced primary hippocampal neurons, we label mGluR2, a neuromodulatory G protein-coupled receptor (GPCR), with dyes optimized for stimulated emission by depletion (STED) super-resolution microscopy, allowing unprecedented accuracy in distinguishing surface and receptors from those in internal compartments of the presynaptic terminal, important in neural communication. This approach offers broad utility for surface-specific protein labelling.


  • DART.2: bidirectional synaptic pharmacology with thousandfold cellular specificity

    by Brenda C. Shields, Haidun Yan, Shaun S. X. Lim, Sasha C. V. Burwell, Celine M. Cammarata, Elizabeth A. Fleming, S. Aryana Yousefzadeh, Victoria Z. Goldenshtein, Elizabeth W. Kahuno, Purav P. Vagadia, et al.

    Precision pharmacology aims to manipulate specific cellular interactions within complex tissues. In this pursuit, we introduce DART.2 (drug acutely restricted by tethering), a second-generation cell-specific pharmacology technology. The core advance is optimized cellular specificity—up to 3,000-fold in 15 min—enabling the targeted delivery of even epileptogenic drugs without off-target effects. Additionally, we introduce brain-wide dosing methods as an alternative to local cannulation and tracer reagents for brain-wide dose quantification. We describe four pharmaceuticals—two that antagonize excitatory and inhibitory postsynaptic receptors, and two that allosterically potentiate these receptors. Their versatility is showcased across multiple mouse-brain regions, including cerebellum, striatum, visual cortex and retina. Finally, in the ventral tegmental area, we find that blocking inhibitory inputs to dopamine neurons accelerates locomotion, contrasting with previous optogenetic and pharmacological findings. Beyond enabling the bidirectional perturbation of chemical synapses, these reagents offer intersectional precision—between genetically defined postsynaptic cells and neurotransmitter-defined presynaptic partners.


  • Open Access

    Natural phasic inhibition of dopamine neurons signals cognitive rigidity

    by Sasha C.V. Burwell, Haidun Yan, Shaun S.X. Lim, Brenda C. Shields, Michael R. Tadross

    When animals unexpectedly fail, their dopamine neurons undergo phasic inhibition that canonically drives extinction learning—a cognitive-flexibility mechanism for discarding outdated strategies. However, the existing evidence equates natural and artificial phasic inhibition, despite their spatiotemporal differences. Addressing this gap, we targeted a GABA A -receptor antagonist precisely to dopamine neurons, yielding three unexpected findings. First, this intervention blocked natural phasic inhibition selectively, leaving tonic activity unaffected. Second, blocking natural phasic inhibition accelerated extinction learning—opposite to canonical mechanisms. Third, our approach selectively benefitted perseverative mice, restoring rapid extinction without affecting new reward learning. Our findings reveal that extinction learning is rapid by default and slowed by natural phasic inhibition—challenging foundational learning theories, while delineating a synaptic mechanism and therapeutic target for cognitive rigidity.


  • Open Access

    "Reward perseveration is shaped by GABAA-mediated dopamine pauses", Burwell et al v1

    by Sasha Burwell, HaiDun not provided, Michael R Tadross

    This collection of protocols details the experiments and analysis performed for the Burwell et al paper "Reward perseveration is shaped by GABAA-mediated dopamine pauses". Software used in the various analysis protocols can be found at https://github.com/tadrosslab/VTA_GABA_paper.


  • Local synaptic inhibition mediates cerebellar granule cell pattern separation and enables learned sensorimotor associations

    by Elizabeth A. Fleming, Greg D. Field, Michael R. Tadross, Court Hull

    The cerebellar cortex has a key role in generating predictive sensorimotor associations. To do so, the granule cell layer is thought to establish unique sensorimotor representations for learning. However, how this is achieved and how granule cell population responses contribute to behavior have remained unclear. To address these questions, we have used in vivo calcium imaging and granule cell-specific pharmacological manipulation of synaptic inhibition in awake, behaving mice. These experiments indicate that inhibition sparsens and thresholds sensory responses, limiting overlap between sensory ensembles and preventing spiking in many granule cells that receive excitatory input. Moreover, inhibition can be recruited in a stimulus-specific manner to powerfully decorrelate multisensory ensembles. Consistent with these results, granule cell inhibition is required for accurate cerebellum-dependent sensorimotor behavior. These data thus reveal key mechanisms for granule cell layer pattern separation beyond those envisioned by classical models.


  • Open Access

    Thousandfold Cell-Specific Pharmacology of Neurotransmission

    by Brenda C. Shields, Haidun Yan, Shaun S.X. Lim, Sasha C. Burwell, Elizabeth A. Fleming, Celine M. Cammarata, Elizabeth W. Kahuno, Purav P. Vagadia, Marie H. Loughran, Lei Zhiquan, et al.

    SUMMARY: Cell-specific pharmaceutical technologies promise mechanistic insight into clinical drugs―those that treat, and often define, human disease. In particular, DART (drug acutely restricted by tethering) achieves genetically programmable control of drug concentration over cellular dimensions. The method is compatible with clinical pharmaceuticals and amenable to studies in behaving animals. Here, we describe DART.2 , comprising three advances. First, we improve the efficiency of chemical capture, enabling cell-specific accumulation of drug to ∼3,000-times the ambient concentration in 15 min. Second, we develop tracer reagents, providing a behavior-independent measure of cellular target engagement in each animal. Third, we extend the method to positive allosteric modulators and outline design principles for this clinically significant class. We showcase the platform with four pharmaceuticals―two that weaken excitatory (AMPAR) or inhibitory (GABA A R) chemical neurotransmission, and two that strengthen these forms of synaptic communication. Across four labs, we tested reagents in the mouse cerebellum, basal ganglia, visual cortex, and retina. Collectively, we demonstrate robust, bidirectional editing of chemical neurotransmission. We provide for distribution of validated reagents, community design principles, and synthetic building blocks for application to diverse pharmaceuticals.


  • Open Access

    An open-source transparent microelectrode array

    by Isaac A Weaver, Austin W Li, Brenda C Shields, Michael R Tadross

    Objective. The micro-electrode array (MEA) is a cell-culture surface with integrated electrodes used for assays of electrically excitable cells and tissues. MEAs have been a workhorse in the study of neurons and myocytes, owing to the scalability and millisecond temporal resolution of the technology. However, traditional MEAs are opaque, precluding inverted microscope access to modern genetically encoded optical sensors and effectors. Approach. To address this gap, transparent MEAs have been developed. However, for many labs, transparent MEAs remain out of reach due to the cost of commercially available products, and the complexity of custom fabrication. Here, we describe an open-source transparent MEA based on the OpenEphys platform (Siegle et al 2017 J. Neural Eng. 14 045003). Main results. We demonstrate the performance of this transparent MEA in a multiplexed electrical and optogenetic assay of primary rat hippocampal neurons. Significance. This open-source transparent MEA and recording platform is designed to be accessible, requiring minimal microelectrode fabrication or circuit design experience. We include low-noise connectors for seamless integration with the Intan Technologies headstage, and a mechanically stable adaptor conforming to the 24-well plate footprint for compatibility with most inverted microscopes.